drugabilis.com
Drugabilis - Drugability for biotech and pharmaceutical research
http://www.drugabilis.com/siteweb-spe-about-us.php?id=1945
Low soluble compounds parenteral formulation. Bull; • •. For 2014, 2015 and 2016. The " Agrément Crédit Impôt Recherche. From the French Ministry of Research. Drugabilis has been accredited since 2006. Bull; • •. Drugabilis is a funding member of the French Association AFSSI. Sciences de la Vie. Bull; • •. Begining of 2006,. Receives confirmation of its Young Innovative Company status. From the French authorities. Bull; • •. Is recognised and supported by Genopole. Bull; • •. Bull; • •.
cardioposition.blogspot.com
Heart Diseases: April 2012
http://cardioposition.blogspot.com/2012_04_01_archive.html
Heart Diseases Cies Search Engine [selected websites]. Quantum Genomics : initiation of a First-in-Human . HeartWare International Expands Intellectual Prope. Friday, April 20, 2012. Quantum Genomics : initiation of a First-in-Human clinical study with QGC001, its lead compound for the treatment of hypertension. April 13th 2012 - Quantum Genomics (NYSE Euronext Paris : MLQGC). Publié par Benjamin de Bélizal. Libellés : Quantum Genomics. Tuesday, April 3, 2012. WorldHeart Corporation's Press Release.
frabioposition.blogspot.com
French Biotechs: April 2011
http://frabioposition.blogspot.com/2011_04_01_archive.html
Pharmaceuticals Search Engine [selected websites]. QUANTUM GENOMICS : POSITIVE SCIENTIFIC RESULTS WIT. CIT : LeadScreen(TM), a new range of fast, cost-e. IN CELL ART teams up with WAKO for the Japanese co. Monday, April 18, 2011. QUANTUM GENOMICS : POSITIVE SCIENTIFIC RESULTS WITH ITS PRODUCT QGC001. 01-04-2011 - Quantum Genomics (NYSE Euronext Paris: MLQGC). Quantum Genomics plans to submit to AFSSAPS in the following weeks, a clinical trial application in order to initiate a single ascending dose (SAD)...
aurgalys.com
Aurgalys connects business to capital
http://www.aurgalys.com/quantum-genomics-alqgc
Investor Relation Equity Research. Jan 19th, 2016: Aurgalys publishes new analyst report on Abivax [Euronext: ABVX]. Nov 25th, 2015: Aurgalys initiates coverage on Sensorion [Euronext: ALSEN]. Smallcap Event, April 11th & 12th, 2016, Paris, France. MidCap Event, October 5th & 6th, 2016, Paris, France. Nov 1st, 2015: Overview of the French MedTech Smallcaps listed in Paris Part 1: Innovation Fuels the MedTech Industry. Quantum Genomics [ALQGC] : . The coverage was initiated November 4th, 2014. Quantum Gen...
SOCIAL ENGAGEMENT